Tag: Kim Dong-chul
Paul Hastings and Jones Day in Meridian Bioscience buyout
South Korea’s healthcare company SD Biosensor and South Korean private equity fund SJL Partners were advised by Paul Hastings in their definitive merger agreement
South Korea’s healthcare company SD Biosensor and South Korean private equity fund SJL Partners were advised by Paul Hastings in their definitive merger agreement
Trademark disputes, regulatory reforms and expansion pressures are forcing businesses to rethink brand protection
Follow us on LinkedIn